Capital International Sarl »

Crispr Therapeutics shares owned by Capital International Sarl

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital International Sarl from 13F filings

Historical chart of Capital International Sarl investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Capital International Sarl consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Capital International Sarl

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.0M 171k 46.98
2024-03-31 $9.7M 142k 68.16
2023-12-31 $6.4M 103k 62.60
2023-09-30 $4.2M 92k 45.39
2023-06-30 $4.8M 85k 56.14
2023-03-31 $3.5M 77k 45.23
2022-12-31 $2.4M 59k 40.65
2022-09-30 $3.3M 50k 65.35
2022-06-30 $1.9M 31k 60.78
2022-03-31 $1.5M 24k 62.76
2021-12-31 $1.5M 20k 75.79
2021-09-30 $440k 3.9k 112.02
2021-06-30 $680k 4.2k 161.83
2021-03-31 $727k 6.0k 121.82
2020-12-31 $1.6M 10k 153.11
2020-09-30 $793k 9.5k 83.61